DKG - Krebsgesellschaft DEGRO
Atzelsberger Kreis für klinische Hyperthermie

Eigene Publikationen

Ausgewählte Publikationen des Atzelsberger Kreises

  • Bruggmoser G, Bauchowitz S, Canters R et al.(2011) Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 187:605-10.
  • Canters RA, Franckena M, van der Zee J et al.(2011) Optimizing deep hyperthermia treatments: are locations of patient pain complaints correlated with modelled SAR peak locations? Phys Med Biol 56:439-51.
  • Canters RA, Franckena M, van der Zee J et al.(2008) Complaint-adaptive power density optimization as a tool for HTP-guided steering in deep hyperthermia treatment of pelvic tumors. Phys Med Biol 53:6799-820.
  • Canters RA, Franckena M, Paulides MM et al.(2008) Patient positioning in deep hyperthermia: influences of inaccuracies, signal correction possibilities and optimization potential. Phys Med Biol 54:3923-36.
  • Cho CH, Wust P, Hildebrandt B et al.(2008) Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators. Int J Hyperthermia 24:399-408.
  • de Bruijne M, Van der Zee J, Ameziane A et al.(2011) Quality control of superficial hyperthermia by treatment evaluation. Int J Hyperthermia 27:199-213.
  • de Bruijne M, van der Holt B, van Rhoon GC et al.(2010) Evaluation of CEM43 degrees CT90 thermal dose in superficial hyperthermia: a retrospective analysis. Strahlenther Onkol 186:436-43.
  • Fatehi D, van der Zee J, van Rhoon GC et al.(2011) Intra-patient comparison between two annular phased array applicators, Sigma-60 and sigma-Eye: Applied RF powers and intraluminally measured temperatures. Int J Hyperthermia 27:214-23.
  • Fatehi D, van der Zee J, de Bruijne M et al.(2007) RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible. Int J Hyperthermia 23:623-43.
  • Fatehi D, van der Zee J, Notenboom A et al.(2007) Comparison of Intratumor and Intraluminal Temperatures During Locoregional Deep Hyperthermia of Pelvic Tumors. Strahlenther Onkol 183:479-86.
  • Franckena M, Canters R, Termorshuizen F et al.(2010) Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia 26:145-57.
  • Franckena M, Fatehi D, de Bruijne M et al.(2009) Hyperthermia dose-effect relationship in 420 patients with cervial cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 45:1969-78.
  • Franckena M, Lutgens LC, Koper PC et al.(2009) Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys 73:242-50.
  • Franckena M, Stalpers LJ, Koper PC et al.(2008) Long-Term Improvement in Treatment Outcome after Radiotherapy and Hyperthermia in Locoregionally Advanced Cervix Cancer: An Update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176-82.
  • Franckena M, De Wit R, Ansink AC et al.(2007) Weekly systemic cisplatin plus locoregional hyperthermia: An effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. Int J Hyperthermia 23:443-50.
  • Frey, B et al.(2012) Old and new facts about hyperthermia induced modulations of the immune system. Int J Hyperthermia 28:528-42.
  • Frey B, Rubner Y, Wunderlich R et al.(2012) Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation – Implications for Cancer Therapies. Curr Med Chem 19:1751-64.
  • Hohenberger P, Wysocki WM et al.(2008) Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose? Oncologist 13:175-86.
  • Hossann M, Wang T, Wiggenhorn M et al.(2010) Size of thermosensitive liposomes influences content release. J. Contr. Release 147:436-44
  • Issels RD, Lindner LH (2010) Hyperthermie. In: Weichgewebetumoren. Interdisziplinäres Vorgehen. Schlag PM, Hartmann JT, Budach VG (Hrsg.) 1st Edition Springer-Verlag 2011 pp 265-272.
  • Issels RD, Lindner LH, Verweij J et al.(2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561-70.
  • Issels, RD et al.(2009) Impact of regional hyperthermia (RHT) on response to neo-adjuvant chemotherapy and survival of patients with high-risk soft-tissue sarcoma (HR-STS): Results of the randomized EORTC-ESHO intergroup trial. Eur J Cancer Suppl 7:3
  • Issels, RD et al.(2008) Regional hyperthermia in high-risk soft tissue sarcomas. Curr Opin Oncol 20:438-43.
  • Issels, RD et al.(2008) Hyperthermia adds to chemotherapy. Eur J Cancer 44:2546-54.
  • Jolesch A, Elmer K, Bendz H, et al.(2011) Hsp70, a messenger from hyperthermia to the immune system. Eur J Cell Biol, 91:48-52.
  • Kukielka AM, Hetnal M, Brandys P et al.(2013) Interstitial hyperthermia of the prostate in combination with brachytherapy : An evaluation of feasibility and early tolerance. Strahlenther Onkol. 2013 Jun;189(6):467-75.
  • Lechner-Tschoep K, Drexler I, Hammer D, et al.(2012) Modified vaccine virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment. Int. J. Hyperthermia 28:33-42.
  • Lindner LH, Issels RD.(2011) Hyperthermia in Soft Tissue Sarcoma. Curr Treat Options Oncol.12:12-20.
  • Lindner LH, Issels RD.(2010) Stellenwert der Hyperthermie im Rahmen der medikamentösen Tumortherapie. Onkologe 16:1063-1071.
  • Lüdemann L, Wust P, Gellermann J et al.(2008) Perfusion measurement using DCE-MRI: implications for hyperthermia. Int J Hyperthermia 24:91-6.
  • Lutgens L, van der Zee J, Pijls-Johannesma M et al.(2010) Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. Cochrane Database Syst Rev 17:CD006377.
  • Maluta S, Dall’oglio S, Nadalini L et al.(2010) Treatment for intermediate and high-risk prostate cancer: Controversial issues and the role of hyperthermia. Int J Hyperthermia 26:765-74.
  • Maluta S, Romano M, Dall’oglio S et al.(2010) Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum. Int J Hyperthermia 26:108-17.
  • Maluta S, Dall’Oglio S, Romano M et al.(2007) Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. Int J Hyperthermia 23:451-6.
  • Milani V, Pazos M, Issels RD et al.(2008) Radiochemotherapy in Combination with Regional Hyperthermia in Preirradiated Patients with Recurrent Rectal Cancer. Strahlenther Onkol 184:163-8.
  • Olson TA.(2013) Hyperthermia in paediatric germ-cell tumours. Lancet Oncol. 2013 Jun 28. [Epub ahead of print]
  • Ott O, Issels RD, Wessalowski R (Hrsg). (2010) Hypertermia in Oncology – Principles and Therapeutic Outlook. 1st edition. Bremen. UNI-MED SCIENCE Verlag.
  • Ott OJ, Rödel C, Weiss C et al.(2009) Radiochemotherapy for bladder cancer. Clin Oncol 21:557-65.
  • Paulides MM, Bakker JF, Linthorst M et al.(2010) The clinical feasibility of deep hyperthermia treatment in the head and neck: new challenges for positioning and temperature measurement. Phys Med Biol 55:2465-80.
  • Paulides MM, Bakker JF, van Rhoon GC et al.(2007) Electromagnetic head-and-neck hyperthermia applicator: Experimental phantom verification and FDTD model. Int J Radiat Oncol Biol Phys 68:612-20.
  • Sauer R, Creeze H, Hulshof M, Issels R, Ott O; Interdisciplinary Working Group for Clinical Hyperthermia (Atzelsberg Circle) of the German Cancer Society and the German Society of Radiooncology (2012) Concerning the final report „Hyperthermia: a systematic review“ of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010. Strahlenther Onkol. 188:209-13.
  • Schildkopf P, Frey B, Ott OJ et al.(2011) Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol 101:109-15.
  • Schildkopf P, Ott OJ, Frey B et al.(2010) Biological rationales and clinical applications of temperature controlled hyperthermia – implications for multimodal cancer treatments. Curr Med Chem 17:3045-57.
  • Schildkopf P, Frey B, Mantel F et al.(2010) Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun 391:1014-20.
  • Schildkopf P, Holmer R, Sieber R et al.(2009) Hyperthermia in combination with X-irradiation induces inflammatory forms of cell death. Autoimmunity 42:311-3.
  • Schlemmer M, Wendtner CM, Lindner L et al.(2010) Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS). Int. J. Hyperthermia, 26:127-135.
  • Schmidtner J, Distel LV, Ott OJ et al.(2009) Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes. Int J Hyperthermia 25:347-54.
  • Stahl R, Wang T, Lindner LH et al.(2009) Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS). Int J Hyperthermia 25:289-98.
  • Van Der Zee J, De Bruijne M, Mens JW et al.(2010) Reirradiation combined with hyperthermia in breast cancer recurrences: Overview of experience in Erasmus MC. Int J Hyperthermia 26:638-48.
  • Van der Zee J, Kroon BB et al.(2008) Isolated limb perfusion for malignant melanoma; possibly better results with high dose hyperthermia. Int J Hyperthermia 24:602-3; authors reply 604.
  • Van der Zee J, Kleynen CE, Nuyttens JJ et al.(2008) Letter to the editor: Hyperthermia to improve results in vaginal cancer. Radiother Oncol 88:286-7.
  • Van der Zee J, Vujaskovic Z, Kondo M et al.(2008) The Kadota Fund International Forum 2004–clinical group consensus. Int J Hyperthermia 24:111-22.
  • Weihrauch M, Wust P, Weiser M et al.(2007) Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Med Phys 34:4717-25.
  • Weiss EM, Frey B, Rödel F et al.(2010) Ex vivo- and in vivo-induced dead tumor cells as modulators of antitumor responses. Ann N Y Acad Sci 1209:109-17.
  • Wessalowski R, Schneider DT, Mils O et al.(2013) Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. Lancet Oncol. 2013 Jun 28. [Epub ahead of print]
  • Wittlinger M, Rödel CM, Weiss C et al.(2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Radiother Oncol 93:358-63.